However, it is still unclear whether iguratimod could alleviate myocardial I/R injury and whether inflammation triggered by NLRP3-related pyroptosis of CFs is involved in this process. This evidence concerns the gene NLRP3 and myalgic encephalomeyelitis/chronic fatigue syndrome.